ATAI Life Sciences's total assets for Q3 2025 were $239.82M, an increase of 26.75% from the previous quarter. ATAI total liabilities were $79.91M for the fiscal quarter, a 76.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.